Skip to main content

Day: July 16, 2020

Registration of share capital reduction

Oslo, 16 July 2020: The Yara International ASA Annual General Meeting on 7 May 2020 approved a capital reduction by cancellation of own shares and by redemption of shares held on behalf of the Norwegian State by the Ministry of Trade, Industry and Fisheries.The share capital of the Company is reduced by NOK 7,259,680 from NOK 463,084,482.90 to NOK 455,824,802.90 by cancellation of 2,724,026 of the Company’s own shares and redemption and cancellation of 1,546,374 shares owned on behalf of the Norwegian State by the Ministry of Trade, Industry and Fisheries.

Continue reading

Registrering av kapitalnedsettelse

Oslo, 16. juli 2020: Yara International ASAs generalforsamling 7. mai 2020 besluttet kapitalnedsettelse ved sletting av egne aksjer og innløsning av aksjer tilhørende den norske stat v/Nærings- og fiskeridepartementet.Selskapets aksjekapital nedsettes med NOK 7.259.680 fra NOK 463.084.482,90 til NOK 455.824.802,90 ved sletting av 2.724.026 av Selskapets egne aksjer og innløsning og sletting av 1.546.374 aksjer eiet av Den norske stat v/Nærings- og fiskeridepartementet.

Continue reading

Westamerica Bancorporation Reports Second Quarter 2020 Financial Results

SAN RAFAEL, Calif., July 16, 2020 (GLOBE NEWSWIRE) — Westamerica Bancorporation (Nasdaq: WABC), parent company of Westamerica Bank, generated net income for the second quarter 2020 of $19.6 million and diluted earnings per common share (“EPS”) of $0.72. These results compare to net income of $17.0 million and EPS of $0.63 for the first quarter 2020 and net income of $19.6 million and EPS of $0.73 for the second quarter 2019.“Westamerica’s primary objective during the Covid-19 pandemic is to support our customers. Westamerica remains open for business during regular business hours at all but one branch. Westamerica funded $249 million Paycheck Protection Program loans for our customers during the second quarter 2020. We are following all health orders affecting our business to keep our customers and employees safe....

Continue reading

Exagen to Announce Second Quarter Financial Results on July 28, 2020

SAN DIEGO, July 16, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that it will release financial results for the quarter ended June 30, 2020 before the market opens on Tuesday, July 28, 2020. Ron Rocca, President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will host a conference call to review the Company’s results at 8:00 AM Eastern Time (5:00 AM Pacific Time).Interested parties may access the conference call by dialing (877) 407-3982 (U.S.) or (201) 493-6780 (international).  Participants wishing to access the call via webcast should use the link posted on the Exagen investor relations website at https://investors.exagen.com/A replay of the conference call will be available...

Continue reading

BioSig Technologies, Inc. Adopts Stockholder Rights Agreement

Westport, CT, July 16, 2020 (GLOBE NEWSWIRE) —Rights Agreement designed to assure stockholders receive fair and equal treatment in the event of any proposed takeoverProvides a guard against tactics to gain control of the Company without paying stockholders a market premium for that controlBioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that its Board of Directors had adopted a stockholder Rights Agreement (the “Rights Agreement”).Due to recent developments, The Board of Directors believes that the current trading price of Common Stock is not reflective of the Company’s intrinsic or long-term value.  The...

Continue reading

Virtusa Achieves AWS End User Computing Competency Status

SOUTHBOROUGH, Mass., July 16, 2020 (GLOBE NEWSWIRE) — Virtusa Corporation (NASDAQ GS:VRTU), a global provider of digital strategy, digital engineering, and IT services and solutions, announced it has achieved the Amazon Web Services (AWS) End User Computing (EUC) Competency. This designation recognizes that Virtusa provides deep expertise in supporting customers that need to provision, protect, and get intelligence from end-point devices, end-user apps, and data on AWS.Premier and Advanced Consulting Partners in the AWS Partner Network (APN) who achieve AWS EUC Competency status provide services and offerings designed to help customers with strategy, professional services, managing infrastructure, repeatable intellectual property, and optimization of EUC technologies on AWS, such as Amazon WorkSpaces, Amazon AppStream 2.0, and Amazon...

Continue reading

Magnetic North Announces Appointment of Vice President of Capital Markets and Granting of Stock Options

**Not for distribution to United States Newswire Services or release publication, distribution or dissemination, directly or indirectly, in the United States.  Any failure to comply with this restriction may constitute a violation of U.S. Securities Laws**CALGARY, Alberta and TORONTO, July 16, 2020 (GLOBE NEWSWIRE) — Magnetic North Acquisition Corp. (TSXV: MNC) (“Magnetic North” or the “Company”), is pleased to announce the appointment of Stephen McCormick as Vice President of Capital Markets of the Company.Mr. McCormick is a senior executive with over twenty years of experience across various industry sectors, including investment management, telecom and information technology. Mr. McCormick has formerly held positions with BMO Nesbitt Burns providing integrated wealth management solutions for high net worth clients, as well as,...

Continue reading

Prefilled Syringes Market to Reach USD 10.57 Billion by 2026; Introduction of BD’s Disposable Autoinjector to Aid Expansion, states Fortune Business Insights™

Pune, July 16, 2020 (GLOBE NEWSWIRE) — The global prefilled syringes market size is expected to reach USD 10.57 billion by 2027, exhibiting a CAGR of 10.5% during the forecast period. The rising prevalence of diabetes can be a vital factor in favoring the growth of the market during the forecast period, states Fortune Business Insights in a report, titled “Prefilled Syringes Market Size, Share & Covid-19 Impact Analysis, By Material (Glass and Plastic) By Closing System (Staked Needle System, Luer Cone System, and Luer Lock Form System) By Product (Complete Syringe Set and Components & Accessories); By Design (Double-chamber, Multiple-chamber, and Single-chamber); By End-user (Pharmaceutical & Biotechnology Companies, Contract Research & Manufacturing Organizations, and Others), and Regional Forecast, 2020-2027”...

Continue reading

Crédit Agricole Normandie Seine : bilan semestriel du contrat de liquidité – Juin 2020

CR CA NORMANDIE SEINE–Siège social : Cité de l’Agriculture, Chemin de la Bretèque – 76230 Bois-Guillaume433 786 738 RCS RouenParis, le 1er juillet 2020Bilan semestriel du contrat de liquidité de la société CR CA NORMANDIE SEINEAu titre du contrat de liquidité confié par la société CR CA NORMANDIE SEINE à Kepler Cheuvreux, à la date du 30 juin 2020, les moyens suivants figuraient au compte de liquidité :3 749 titres261 476.04 € en espècesNombre de transactions exécutées sur le semestre à l’achat : 265Nombre de transactions exécutées sur le semestre à la vente : 186Volume échangé sur le semestre à l’achat : 2 465 titres pour 337 596.80 €Volume échangé sur le semestre à la vente : 1 237 titres pour 181 237.56 €  ————————————————————————————Il...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.